Role of quinoids in estrogen carcinogenesis

Chemical Research in Toxicology

Volumn 11, Issue 10, 1998, Pages 1113-1127

  Bolton, Judy L ^a   Pisha, Emily ^a   Zhang, Fagen ^a   Qiu, Shengxiang ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL ESTROGEN; CONJUGATED ESTROGEN; CYTOCHROME P450 REDUCTASE; DNA; EQUILENIN; EQUILIN; ESTRADIOL; ESTROGEN; ESTRONE; GLUTATHIONE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

CANCER RISK; DNA ADDUCT; DNA ALKYLATION; DRUG CARCINOGENICITY; DRUG CYTOTOXICITY; DRUG HYDROXYLATION; ESTROGEN METABOLISM; ESTROGEN THERAPY; FEMALE; HORMONE SENSITIVITY; HUMAN; ISOMERISM; NONHUMAN; OXIDATION REDUCTION STATE; REVIEW;

ANIMALS; BIOTRANSFORMATION; DNA; ESTROGENS; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; QUINONES;

EID: 0031741669     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx9801007     Document Type: Review

References (150)

1. Henderson, B. E., Ross, R., and Bernstein, L. (1988) Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 48, 246-253.
2. Feigelson, H. S., and Henderson, B. E. (1996) Estrogens and breast cancer. Carcinogenesis 17, 2279-2284.
3. Liehr, J. G. (1990) Genotoxic effects of estrogens. Mutat. Res. 238, 269-276.
4. Henderson, B. E., ROSS, R. K., and Pike, M. C. (1991) Toward the primary prevention of cancer. Science 254, 1131-1138.
5. Service, R. F. (1998) New role for estrogen in cancer? Science 279, 1631-1633.
6. Green, S. (1992) Nuclear receptors and chemical carcinogenesis. Trends Pharmacol. Sci. 13, 251-255.
7. Yager, J. D., and Liehr, J. G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36, 203-232.
8. Zhu, B. T., and Conney, A. H. (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19, 1-27.
9. Li, J. J., Li, S. A., Gustafsson, J. A., Nandi, S., and Sekely, L. I., Eds. (1996) Hormonal Carcinogenesis II, Springer-Verlag, New York.
10. Liehr, J. G. (1983) 2-Fluoroestradiol. Separation of Estrogenicity from Carcinogenicity. Mol, Pharmacol. 23, 278-281.
11. Li, J. J., and Li, S. A. (1984) Estrogen-induced tumorigenesis in hamsters: Roles for hormonal and carcinogenic activities. Arch. Toxicol. 55, 110-118.
12. Breimer, L. H. (1990) Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis. The role of DNA base damage. Mol. Carcinog. 3, 188-197.
13. Vassilopoulou-Sellin, R. (1993) Estrogen replacement therapy in women at increased risk for breast cancer. Breast Cancer Res. Treat. 28, 167-177.
14. Lupulescu, A. (1995) Estrogen Use and Cancer Incidence: A Review. Cancer Invest. 13, 287-295.
15. Davidson, N. E. (1995) Hormone-Replacement Therapy-Breast Versus Heart Versus Bone. N. Engl. J. Med. 332, 1638-1639.
16. Zurnoff, B. (1998) Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy. Proc. Soc. Exp. Biol. Med. 217, 30-37.
17. Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., and Speizer, F. E. (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332, 1589-1593.
18. Steinberg, K. K., Smith, S. J., Thacker, S. B., and Stroup, D. F. (1994) Breast cancer risk and duration of estrogen use: The role of study design in meta-analysis. Epidemiology 5, 415-421.
19. Grady, D., Gebretsadik, T., Kerlikowske, K., Ernster, V., and Petitti, D. (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol. (N.Y.) 85, 304-313.
20. Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., Hennekens, C. H., and Speizer, F. E. (1997) Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336, 1769-1775.
21. Paganinihill, A. (1995) Estrogen replacement therapy and stroke. Prog. Cardiovasc. Dis. 38, 223-242.
22. Wickelgren, I. (1997) Estrogen: A new weapon against Alzheimer's. Science 276, 676-677.
23. Henderson, V. W. (1997) The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 48, S27-S35.
24. Haskell, S. G., Richardson, E. D., and Horwitz, R. I. (1997) The effect of estrogen replacement therapy on cognitive function in women; A critical review of the literature. J. Clin. Epidemiol. 50, 1249-1264.
25. American Druggist Merchandising (1996) The top 200 drugs. 18-20 (February issue).
26. Li, J. J., Li, S. A., Oberley, T. D., and Parsons, J. A. (1995) Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. Cancer Res. 55, 4347-4351.
27. Judd, H. L., Mebane-Sims, I., Legault, C., Wasilauskas, C., Johnson, S., Merino, M., Barrett-Connor, B., and Trabal, J. (1996) Effects of hormone replacement therapy on endometrial histology in postmenopausal women. JAMA, J. Am. Med. Assoc. 275, 370-375.
28. Lyman, G. W., and Johnson, R. N. (1982) Assay for conjugated estrogens in tablets using fused-silica capillary gas chromatography. J. Chromatogr. 234, 234-239.
29. Maclusky, N. J., Naftolin, F., Krey, L. C., and Franks, S. (1981) The catechol estrogens. J. Steroid Biochem. 15, 111-124.
30. Fishman, J. (1983) Aromatic hydroxylation of estrogens. Annu. Rev. Physiol. 45, 61-72.
31. Ball, P., and Knuppen, R. (1980) Catecholoestrogens (2- and 4-Hydroxyoestrogens): Chemistry, Biogenesis, Metabolism, Occurrence and Physiological Significance. Acta Endocrinol., Suppl. 232, 1-127.
32. Dannan, G. A., Porubek, D. J., Nelson, S. D., Waxman, D. J., and Guengerich, F. P. (1986) 17β-Estradiol 2- and 4-hydroxylation catalysed by rat hepatic cytochrome P450: role of individual forms, inductive effects, developmental patterns, and alterations by gonadectomy and hormone replacement. Endocrinology 118, 1952-1960.
33. Suchar, L. A., Chang, R. L., Thomas, P. E., Rosen, R. T., Lech, J., and Conney, A. H. (1996) Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17β-estradiol by liver microsomes from female rats. Endocrinology 137, 663-676.
34. Guengerich, F. P. (1988) Oxidation of 17a-ethylestradiol by human liver cytochrome P450. Mol. Pharmacol. 33, 500-508.
35. Martucci, C. P., and Fishman, J. (1993) P450 enzymes of estrogen metabolism. Pharmacol. Ther. 57, 237-257.
36. Spink, D. C., Hayes, C. L., Young, N. R., Christou, M., Sutter, T. R., Jefcoate, C. R., and Gierthy, J. F. (1994) The Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Estrogen Metabolism in MCF-7 Breast Cancer Cells: Evidence for Induction of a Novel 17βEstradiol 4-Hydroxylase. J. Steriod Biochem. Mol. Biol. 51, 251-258.
37. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. (1996) 17β-Estradiol hydroxylation catalyzed by human P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 93, 9776-9781.
38. Spink, D. C., Spink, B. C., Cao, J. Q., Gierthy, J. F., Hayes, C. L., Li, Y., and Sutter, T. R. (1997) Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 62, 223-232.
39. Spink, D. C., Spink, B. C., Cao, J. Q., Depasquale, J. A., Pentecost, B. T., Fasco, M. J., Li, Y., and Sutter, T. R. (1998) Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19, 291-298.
40. Wolff, M. S., Toniolo, P. G., Lee, E. W., Rivera, M., and Dubin, N. (1993) Blood levels of organochlorine residues and risk of breast cancer. J. Natl. Cancer Inst. 85, 648-652.
41. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. (1996) 17β-Eetradiol hydroxylation catalyzed by human P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 93, 9776-9781.
42. Kirkman, H. (1959) Estrogen-induced tumors of the kidney III. Growth characteristics in the Syrian hamster. Natl. Cancer Inst. Monogr. 1, 1-57.
43. Liehr, J. G., Fang, W. R., Sirbasku, D. A., and Ari-Ulubelen, A. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24, 353-356.
44. Li, J. J., and Li, S. A. (1987) Estrogen carcinogenesis in Syrian hamster tissues: Role of metabolism. Fed. Proc. 46, 1858-1863.
45. Liehr, J. G. (1997) Hormone-associated cancer: Mechanistic similarities between breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ. Health Perspect. 105 (S3), 565-569.
46. Liehr, J. G., and Ricci, M. J. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. U.S.A. 93, 3294-3296.
47. Nebert, D. W. (1993) Elevated estrogen 16α-hydroxylase activity: Is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? J. Natl Cancer Inst. 85, 1888-1891.
48. van Aswegen, C. H., Purdy, R. H., and Wittliff, J. L. (1989) Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. J. Steroid Biochem. 32, 485-492.
49. Swaneck, G. E., and Fishman, J. (1988) Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradil receptor in human breast cancer cells: Characterization and intranuclear localization. Proc. Natl. Acad. Sci. U.SA. 85, 7831-7835.
50. Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton, C. H. (1993) Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ. Health Perspect. 101, 372-377.
51. Newfield, L., Bradlow, H. L., Sepkovic, D. W., and Auborn, K. (1998) Estrogen metabolism and the malignant potential of human papillomavirus immortalized keratinocytes. Proc. Soc. Exp. Biol Med. 217, 322-326.
52. Fishman, J., Schneider, J., and Hershcopf, R. J. (1984) Increased estrogen- 16α-hydroxylase activity in women with breast and endometrial cancer. J. Steroid Biochem. 20, 1077-1081.
53. Adlercreutz, H., Fotsis, T., and Hockerstedt, K. (1989) Diet and urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J. Steroid Biochem. 34, 527-530.
54. 1) in postmenopausal women with and without breast cancer. Environ. Health Perspect. 105 (S3), 601-605.
55. Huffman, A. R., Paul, S. M., and Axelrod, J. (1979) Catecholestrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res. 39, 4584-4587.
56. Adlercreutz, H., Gorbach, S. L., Goldin, B. R., Woods, M. N., Dwyer, J. T., and Hamalainen, E. (1994) Estrogen metabolism and excretion in oriental and Caucasian women. J. Natl. Cancer Inst. 86, 1076-1082.
57. Nagata, C., Kabuto, M., Kurisu, Y., and Shimizu, H. (1997) Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr. Cancer 29, 228-233.
58. Dunn, J. E. (1975) Cancer epidemiology in populations of the United States with emphasis on Hawaii and California and Japan. Cancer Res. 35, 3240-3245.
59. Purdy, R. H., Moore, P. H., Williams, M. C., Goldzheher, H. W., and Paul, S. M. (1982) Relative rates of 2- and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. FEBS Lett. 138, 40-44.
60. Li, S. A., Klicka, J. K., and Li, J. J. (1985) Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res. 45, 181-185.
61. Sarabia, S. F., Zhu, B. T., Kurosawa, T., Tohma, M., and Liehr, J. G. (1997) Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens. Chem. Res. Toxicol. 10, 767-771.
62. Bhavnani, B. R. (1998) Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: Chemistry and metabolism. Proc. Soc. Exp. Biol. Med. 217, 6-16.
63. Gelbke, H. P., Haupt, O., and Knuppen, R. (1973) A simple chemical method for the synthesis of catechol estrogens. Steroids 21, 205-217.
64. Shen, L., Pisha, E., Huang, Z., Pezzuto, J. M., Krol, E., Alain, Z., van Breemen, R. B., and Bolton, J. L. (1997) Bioreductive activation of catechol estrogen-ortho-quinones: Aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18, 1093-1101.
65. Rao, P. N., and Somawardhana, C. W. (1987) Synthesis of 2-methoxy and 4-methoxy equine estrogens. Steroids 49, 419-432.
66. Sugumaran, M. (1991) Molecular mechanisms for mammalian melanogenesis: Comparison with insect cuticular sclerotization. FEBS Lett. 293, 233-239.
67. O'Brien, P. J. (1991) Molecular mechanisms of quinone cytotoxicity. Chem.-Biol. Interact. 80, 1-14.
68. Sepkovic, D. W., Bradlow, H. L., Michnovicz, J., Murtezani, S., Levy, I., and Osborne, M. P. (1994) Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-naphthaflavone; A comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods. Steroids 59, 318-323.
69. Purdy, R. H., Moore, P. H., Williams, M. C., Goldzheher, H. W., and Paul, S. M. (1982) Relative rates of 2- and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. FEBS Lett. 138, 40-44.
70. Butter-worth, M., Lau, S. S., and Monks, T. J. (1996) 17β-Estradiol metabolism by hamster hepatic microsomes; Comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation. Chem. Res. Toxicol. 9, 793-799.
71. Iverson, S. L., Shen, L., Anlar, N., and Bolton, J. L. (1996) Bioactivation of estrone and its catechol metabolites to quinoidglutathione conjugates in rat liver microsomes. Chem. Res. Toxicol. 9, 492-499.
72. Butterworth, M., Lau, S. S., and Monks, T. J. (1997) Formation of catechol estrogen glutathione conjugates and gamma-glutamyl transpeptidase-dependent nephrotoxicity of 17-β-estradiol in the golden Syrian hamster. Carcinogenesis 18, 561-567.
73. Chardarian, C. G., and Castagnoli, N. (1979) Synthesis, redox characteristics, and in vitro norepinephrine uptake inhibiting properties of 2-(2-mercapto-4,5-dihydroxyphenyl)ethylamine (6-mercaptodopamine). J. Med. Chem. 22, 1317-1322.
74. Numazawa, M., and Nambara, T. (1977) A new mechanism of in vitro formation of catechol estrogen glutathione conjugates by rat liver microsomes. J. Steroid Biochem. 8, 835-840.
75. Abul-Hajj, Y. J., and Cisek, P. L. (1986) Regioselective reaction of thiols with catechol estrogens and estrogen-o-quinones. J. Steroid Biochem. 25, 245-247.
76. Abul-Hajj, Y. J., and Cisek, P. L. (1988) Catechol estrogen adducts. J. Steroid Biochem. 31, 107-110.
77. Nishinaga, A., Itahara, T., and Matsuura, T. (1974) Base-catalyzed oxygenation of 3,5-Di-tert-butylpyrocatechol and its related compounds. Bull. Chem. Soc. Jpn. 47, 1811-1812.
78. Eliseev, A. V., and Yatsimirskii, A. K. (1994) Dual effect of cyclodextrins on catechol autoxidation. J. Org. Chem. 59, 264-265.
79. Smithgall, T. E., Harvey, R. G., and Penning, T. M. (1988) Spectroscopic identification of ortho-quinones as the products of polycyclic aromatic trans-dihydrodiol oxidation catalyzed by dihydrodiol dehydrogenase. J. Biol. Chem. 263, 1814-1820.
80. Penning, T. M. (1993) Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism. Chem.-Biol. Interact. 89, 1-34.
81. Chang, M., Zhang, F., Shen, L., Pauss, N., Alam, I., van Breemen, R. B., Blond-Elguindi, S., and Bolton, J. L. (1998) Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens. Chem. Res. Toxicol. 11, 758-765.
82. Bolton, J. L., and Shen, L. (1996) p-Quinone methides are the major decomposition products of catechol estrogen o-quinones. Carcinogenesis 17, 925-929.
83. Li, S. A., Purdy, R. H., and Li, J. J. (1989) Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity. Carcinogenesis 10, 63-67.
84. Bolton, J. L., Acay, N. M., and Vukomanovic, V. (1994) Evidence that 4-allyl-ortho-quinones spontaneously rearrange to their more electrophilic quinone methides: Potential bioactivation mechanism for the hepatocarcinogen safrole. Chem. Res. Toxicol. 7, 443-450.
85. Iverson, S. L., Hu, L. Q., Vukomanovic, V., and Bolton, J. L. (1995) The influence of the para-alkyl substituent on the isomerization of o-quinones to p-quinone methides: Potential bioactivation mechanism for catechols. Chem. Res. Toxicol. 8, 537-544.
86. Bolton, J. L., Wu, H. M., and Hu, L. Q. (1996) The mechanism of isomerization of 4-propyl-o-quinone to its tautomeric p-quinone methide. Chem. Res. Toxicol. 9, 109-113.
87. Ruiz, L. M., Garrido, M. J., and Lacort, M. (1993) Estradiolinduced effects on glutathione metabolism in rat hepatocytes. J. Biochem. (Tokyo) 113, 563-567.
88. Brunmark, A., and Cadenas, E. (1990) Biological implications of the nucleophilic addition of glutathione to quinoid compounds. In Glutathione: Metabolism and physiological functions (Vina, J., Ed.) pp 279-294, CRC Press, Boca Raton, FL.
89. Monks, T. J., and Lau, S. S. (1992) Toxicology of quinonethioethers. Crit. Rev. Toxicol. 22, 243-270.
90. Monks, T. J., and Lau, S. S. (1997) Biological reactivity of polyphenolic glutathione conjugates. Chem. Res. Toxicol. 10, 1296-1313.
91. Meunier, G., De Montauzon, D., Bernadou, J., Grassy, G., Bonnadous, M., Cros, S., and Meunier, B. (1987) The Biooxidation of Cytotoxic Ellipticine Derivatives: A Key to Structure-Activity Relationship Studies? Mol. Pharmacol. 33, 93-102.
92. Driacoll, J. S. (1979) Catecholamine Analogs as Potential Antitumor Agents. J. Pharm. Sci. 68, 1519-1521.
93. Cai, P., Snyder, J. K., Chen, J.-C., Fine, R., and Volicer, L. (1990) Preparation, Reactivity, and Neurotoxicity of Tryptamine-4,5-Dione. Tetrahedron Lett, 31, 969-972.
94. Liberate, D. J., Byers, V. S., Dennick, R. G., and Castagnoli, N. (1981) Regiospecific attack of nitrogen and sulfur nucleophiles on quinones derived from poison oak/ivy catechols (urushiols) and analogues as models for urushiol-protein conjugate formation. J. Med. Chem. 24, 28-33.
95. Nelson, S. D., Mitchell, J. R., Dybing, E., and Sasame, H. A. (1976) Cytochrome P450-mediated oxidation of 2-hydroxyestrogens to reactive intermediates. Biochem. Biophys. Res. Commun. 70, 1157-1165.
96. Freyberger, A., and Degen, G. H. (1989) Covalent binding to proteins of reactive intermediates resulting from prostaglandin H synthase-catalyzed oxidation of stilbene and steroid estrogens. J. Biochem. Toxicol. 4, 95-103.
97. Tabakovic, K., and Abul-Hajj, Y. (1994) Reaction of lysine with estrone 3,4-o-quinone. Chem. Res. Toxicol. 7, 696-701.
98. Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., and Graham, D. G. (1992) Contemporary issues in toxicology; Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 112, 2-16.
99. Wang, M., and Liehr, J. G. (1994) Identification of fatty acid hydro peroxide cofactors in the cytochrome P450-mediated oxidation of estrogens to quinone metabolites. Role and balance of lipid peroxides during estrogen-induced carcinogenesis. J. Biol. Chem. 269, 284-291.
100. Wang, M. Y., and Liehr, J. G. (1995) Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehydeDNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 16, 1941-1945.
101. Shigenaga, M. K., and Ames, B. N. (1991) Assays for 8-hydroxy2'-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radical Biol. Med. 10, 211-216.
102. Powis, G. (1987) Metabolism and Reactions of Quinoid Anticancer Agents. Pharmacol. Ther. 35, 57-162.
103. Thompson, D. C., Thompson, J. A., Sugumaran, M., and Moldeus, P. (1992) Biological and toxicological consequences of quinone methide formation. Chem.-Biol. Interact. 86, 129-162.
104. Peter, M. G. (1989) Chemical modification of biopolymers with quinones and quinone methides. Angew. Chem. 101, 572-587.
105. Lewis, M. A., Yoerg-Graff, D., Bolton, J. L., and Thompson, J. A. (1996) Alkylation of 2'-Deoxynucleosides and DNA by Quinone Methides Derived from 2,6-Di-tert-butyl-4-methylphenol. Chem. Res. Toxicol. 9, 1368-1374.
106. Bolton, J. L., Turnipseed, S. B., and Thompson, J. A. (1997) Influence of quinone methide reactivity on the alkylation of thiol and amino groups in proteins: studies utilizing amino acid and peptide models, Chem.-Biol. Interact. 107, 185-200.
107. Richard, J. P., Amyes, T. L., Bei, L., and Stubblefield, V. (1990) The effect of β-fluorine substituents on the rate and equilibrium constants for the reactions of α-substituted 4-methoxybenzyl carbocations and on the reactivity of a simple quinone methide. J. Am. Chem. Soc. 112, 9513-9519.
108. Hulbert, P. B., and Grover, P. L. (1983) Chemical rearrangement of phenol-epoxide metabolites of polycyclic aromatic hydrocarbons to quinone-methides. Biochem. Biophys. Res. Commun. 117, 129-134.
109. Brunmark, A., and Cadenas, E. (1989) Redox and Addition Chemistry of Quinoid Compounds and its Biological Implications. Free Radical Biol. Med. 7, 435-477.
110. Beall, H. D., Liu, Y., Siegel, D., Bolton, E. M., Gibson, N. W., and Ross, D. (1996) Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin. Biochem. Pharmacol. 51, 645-652.
111. Schlager, J. J., and Powis, G. (1990) Cytosolic NAD(P)H:quinone acceptor oxidoreductase in human normal and tumor tissue. Effects of cigarette smoking and alcohol. Int. J. Cancer 45, 403-409.
112. Nutter, L. M., Zhou, B., Sierra, E. E., Wu, Y. Y., Rummel, M. M., Gutierrez, P., and Abul-Hajj, Y. J. (1994) Cellular biochemical determinants modulating the metabolism of estrone 3,4-quinone. Chem. Res. Toxicol. 7, 609-613.
113. Nutter, L. M., Wu, Y., Ngo, E. O., Sierra, E. E., Gutierrez, P. L., and Abul-Hajj, Y. J. (1994) An o-quinone form of estrogen produces free radicals in human breast cancer cells: Correlation with DNA damage. Chem. Res. Toxicol. 7, 23-28.
114. Roy, D., and Liehr, J. G. (1988) Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters: Increased Superoxide formation by redox cycling of estrogen. J. Biol. Chem. 263, 3646-3651.
115. Geran, R. I., Greenberg, N. H., McDonald, M. M., Schumacher, A. M., and Abbott, B. J. (1972) Protocols for screening chemical agents and natural products against animal tumors and other biological systems (third edition). Cancer Chemother. Rep. 3, 1-103.
116. Likhitwitayawuid, K., Angerhofer, C. K., Cordeil, G. A., and Pezzuto, J. M. (1993) Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania Erecta, J. Nat. Prod. 56, 3038.
117. Pisha, E., and Pezzuto, J. M. (1997) Cell-based assay for the determination of estrogenic and anti-estrogenic activities. Methods Cell Sci. 19, 37-43.
118. Bolton, J. L., Pisha, E., Shen, L., Krol, E. S., Iverson, S. L., Huang, Z., van Breemen, R. B., and Pezzuto, J. M. (1997) The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkycatechol-induced toxicity in human melanoma cells. Chem.-Biol. Interact. 106, 133-148.
119. Malins, D. C., Polissar, N. L., and Gunselman, S. J. (1996) Progession of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. U.S.A. 93, 2557-2563.
120. Shigenaga, M. K., and Ames, B. N. (1991) Assays for 8-hydroxy2'-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radical Biol. Med. 10, 211-216.
121. Floyd, R. A. (1990) The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11, 1447-1450.
122. Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., and Graham, D. G. (1992) Contemporary issues in toxicology: Quinone chemistry and toxicity. Toxicol. Appl. Pharmacol. 112, 2-16.
123. Han, X., and Liehr, J. G. (1994) 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol. Role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54, 5515-5517.
124. Nutter, L. M., Ngo, E. O., and Abul-Hajj, Y. J. (1991) Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. J. Biol. Chem. 266, 16380-16386.
125. Han, X., and Liehr, J. G. (1994) 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol. Role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54, 5515-5517.
126. Li, J. J., Gonzalez, A., Banerjee, S., Banerjee, S. K., and Li, S. A. (1993) Estrogen carcinogenesis in the hamster kidney: role of cytotoxicity and cell proliferation. Environ. Health Perspect. 5, 259-264.
127. Banerjee, S. K., Banerjee, S., Li, S. A., and Li, J. J. (1994) Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. Mutat. Res. 311, 191-197.
128. Roy, D., and Liehr, J. C. (1990) Inhibition of estrogen-induced kidney carcinogenesis in Syrian hamsters by modulators of estrogen metabolism. Carcinogenesis 11, 567-570.
129. Liehr, J. G. (1991) Vitamin C reduces the incidence and severity of renal tumors induced by estradiol or diethylstilbestrol. Am. J. Clin. Nutr. 54, 1256S-1260S.
130. Malins, D. C., and Haimanot, R. (1991) Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 51, 5430-5432.
131. Malins, D. C., Holmes, E. H., Polissar, N. L., and Gunselman, S. J. (1993) The etiology of breast cancer. Cancer 71, 3036-3043.
132. Chen, Y., Shen, L., Zhang, F., Lau, S. S., van Breemen, R. B., Nikolic, D., and Bolton, J. L. (1998) The equine estrogen metabolite 4-hydroxyequilenin causes DNA single strand breaks and oxidation of DNA bases in vitro. Chem. Res. Toxicol (in press).
133. Han, X., and Liehr, J. G. (1995) Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16, 2571-2574.
134. Kamiya, H., Miura, H., Muratakamiya, N., Ishikawa, H., Sakaguchi, T., Inoue, H., Sasaki, T., Masutani, C., Hanaoka, F., Nishimurra, S., and Ohtsuka, E. (1995) 8-Hydroxyadenine (7,8-dihydro-8-oxoadenine) induces misincorporation in in vitro DNA synthesis and mutations in NIH 3T3 cells. Nucleic Acids Res. 23, 2893-2899.
135. Kuchino, Y., Mari, F., Kasai, H., Inoue, H., Iwai, S., Miura, K., Ohtsuka, E., and Nishimura, S. (1987) Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 327, 77-79.
136. Klaassen, C. D. (1996) Casarett & Doull's Toxicology: The basic science of poisons, McGraw-Hill, New York.
137. Singer, B., and Hang, B. (1997) What structual features determine repair enzyme specificity and mechanism in chemically modified DNA? Chem. Res. Toxicol. 10, 713-732.
138. Liehr, J. G., Avitts, T. A., Randerath, B., and Randerath, K. (1986) Estrogen-induced endogenous DNA adduction; Possible mechanism of hormonal cancer, Proc. Natl. Acad. Sci U.S.A. 83, 5301-5305.
139. Liehr, J. G-, Hall, E. R., Avitts, T. A., Randerath, E., and Randerath, K. (1987) Localization of estrogen-induced DNA adducts and cytochrome P450 activity at the site of renal carcinogenesis in the hamster kidney. Cancer Res. 47, 2156-2159.
140. 32P-postlabeling in the dorsolateral prostrate of NBL/Cr rats treated with estradiol-17β and testosterone. Carcinogenesis 16, 951-954.
141. Dwivedy, I., Devanesan, P., Cremonesi, P., Rogan, E., and Cavalieri, E. (1992) Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem. Res. Toxicol. 5, 828-833.
142. Roy, D., and Abul-Hajj, Y. J. (1997) Estrogen-nucleic acid adducts; guanine is major site for interaction between 3,4-estrone quinone and COIII gene. Carcinogenesis 18, 1247-1249.
143. Abul-Hajj, Y. J., Tabakovic, K., and Tabakovic, I. (1995) An estrogen-nucleic acid adduct. Electroreductive intermolecular coupling of 3,4-estrone-o-quinone and adenine. J. Am. Chem. Soc. 117, 6144-6145.
144. Akanni, A., Tabakovic, K., and Abul-Hajj, Y. J. (1997) Estrogennucleic acid adducts; Reaction of 3,4-estrone-o-quinone with nucleic acid bases. Chem. Res. Toxicol. 10, 477-481.
145. Akanni, A., and Abul-Hajj, Y. J. (1997) Estrogen-nucleic acid adducts; Reaction of 3,4-estrone-o-quinone radical anion with deoxynucleosides. Chem. Res. Toxicol. 10, 760-766.
146. Stack, D. E., Byun, J., Gross, M. L., Rogan, E. G., and Cavalieri, E. L. (1996) Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9, 851-859.
147. Loeb, L. A., and Preston, B. D. (1986) Mutagenesis by apurinic/ apyrimidinic sites. Annu. Rev. Genet. 20, 201-203.
148. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L., and Rogan, E. G. (1997) Molecular origin of cancer; Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U.S.A. 94, 10937-10942.
149. Shen, L., Qiu, S., van Breemen, R. B., Zhang, F., Chen, Y., and Bolton, J. L. (1997) Reaction of the Premarin metabolite 4-hydroxyequilenin semiquinone radical with 2'-deoxyguanosine: Formation of unusual cyclic adducts. J. Am. Chem. Soc. 119, 11126-11127.
150. Shen, L., Qiu, S., Chen, Y., Zhang, F., van Breemen, R. B., Nikolic, D., and Bolton, J. L. (1998) Alkylation of 2'-deoxynucleosides and DNA by the Premarin metabolite 4-hydroxyequilenin semiquinone radical. Chem. Res. Toxicol. 11, 94-101.